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ABSTRACT
Background: Physical inactivity is often associated with positive
energy balance and fat gain.
Objective: We aimed to assess whether energy intake in excess of
requirement activates systemic inflammation and antioxidant de-
fenses and accelerates muscle atrophy induced by inactivity.
Design: Nineteen healthy male volunteers were studied before and
at the end of 5 wk of bed rest. Subjects were allowed to spontaneously
adapt to decreased energy requirement (study A, n  10) or were
provided with an activity-matched diet (study B, n9). Groups with
higher (HEB) or lower (LEB) energy balance were identified ac-
cording to median values of inactivity-induced changes in fat mass
(FM, assessed by bioelectrical impedance analysis).
Results: In pooled subjects (n  19; median FM: 1.4 kg), bed
rest–mediated decreases in fat-free mass (bioelectrical impedance
analysis) and vastus lateralis thickness (ultrasound imaging) were
significantly greater (P0.03) in HEBAB (3.80.4 kg and0.32
 0.04 cm, respectively) than in LEBAB (2.3 0.5 kg and0.09
 0.04 cm, respectively) subjects. In study A (medianFM: 1.8 kg),
bed rest–mediated increases in plasma leptin, C-reactive protein, and
myeloperoxidase were greater (P  0.04) in HEBA than in LEBA
subjects. Bed rest–mediated changes of glutathione synthesis rate in
eythrocytes (L-[3,3-2H2]cysteine incorporation) were greater (P 
0.03) in HEBA (from 70 19 to 164 29%/d) than in LEBA (from
103 23 to 84 27%/d) subjects.
Conclusions: Positive energy balance during inactivity is associated
with greater muscle atrophy and with activation of systemic inflam-
mation and of antioxidant defenses. Optimizing caloric intake may
be a useful strategy for mitigating muscle loss during period of
chronic inactivity. Am J Clin Nutr 2008;88:950–8.
INTRODUCTION
Fiber atrophy and changes in contractile properties are in-
volved in the adaptation of skeletal muscle to unloading (1, 2).
Physical inactivity also is associated with resistance to insulin
glucoregulatory action (3) and lower energy requirements (4).
Energy intake (EI) should therefore be adapted to avoid positive
balance and the preferential deposition of fat tissue in visceral
compartments (5). Experimental bed rest in healthy volunteers is
a suitable model in which to investigate physiologic adaptation to
inactivity. Most previous studies have shown that, when EI was
not strictly controlled, fat mass tended to increase in parallel to
lean body mass catabolism (6–14).
Overfeeding and excess body fat increase leptin secretion and
are associated with low-grade inflammatory response and
greater oxidative stress (15, 16). Proinflammatory mediators and
redox unbalance potentially play a causative role in lowering
muscle protein synthesis and in accelerating proteolysis (17, 18).
Overfeeding led to a significant reduction in the protein frac-
tional synthesis rate (FSR) in muscle of rats (19). Systemic in-
flammation upregulates cellular antioxidant defenses, including
the thiol (functional group composed of a sulfur atom and a
hydrogen atom; -SH) tripeptide (L--glutamyl-L-cysteinylglycine)
glutathione (20), which is highly concentrated in erythrocytes and
which provides local and systemic antioxidant protection (21).
The current study was conducted to test the hypothesis that
positive energy balance (ie, EI in excess of requirements) leading
to fat deposition could accelerate inactivity-induced loss of lean
mass and could activate systemic inflammation, free radical pro-
duction, and antioxidant defenses. Energy balance was deter-
mined from the overall 35-d change in body fat mass, as deter-
mined by bioelectrical impedance analysis [BIA (22)], and from
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changes in leptin concentration (23). Evaluation of antioxidant
defenses included determination of erythrocyte glutathione turn-
over by the incorporation of stable isotope (24).
SUBJECTS AND METHODS
Subjects and experimental design
Nineteen healthy male subjects [x SEM age: 24 1 y; body
mass index (in kg/m2): 23.5 0.6] were selected to investigate
the effects of experimental bed rest at different EIs. Ten subjects
were studied in July and August 2006 (study A), and 9 subjects
were studied in July and August 2007 (study B). All subjects
were physically active before admission to the Valdoltra Hospi-
tal, University of Primorska (Ankaran-Capodistria, Slovenia).
Their body mass was stable for3 mo before the studies.
Routine medical and laboratory analyses were performed to
exclude chronic diseases. None of the subjects were regularly
taking any medication. The experiments were part of compre-
hensive, international collaborative bed-rest studies. The bed-
rest periods were preceded by a 1-wk ambulatory adaptation
period, in which each subject received a weight-maintaining diet
containing 1.4 times his resting energy expenditure, calculated
by using the FAO/WHO equations (25). The diet contained
60% of energy as carbohydrate, 25% as fat, and 15% as protein.
Six meals were administered daily: 3 main meals (breakfast,
lunch, and dinner) and 3 snacks. During the 35-d bed-rest period
of study A, a diet with the same energy, frequency, and relative
macronutrient content of that planned in the ambulatory adapta-
tion period was offered to subjects. Subjects were not required to
consume all served food, but they were allowed to adapt spon-
taneously to decreased energy requirements during inactivity.
Leftover food was monitored semiquantitatively by an expert
dietitian to assess the relative macronutrient intake. During the
35-d bed-rest period of study B, each subject received an activity-
adjusted diet containing 1.2 times his resting energy expenditure
(25) and with the same meal frequency and relative macronutri-
ent content of that planned in study A. Subjects were required to
consume all food served.
The body composition of all subjects was measured by using
BIA [Human IM Plus; DS Dietosystem, Milan, Italy (22)] at the
end of both the ambulatory adaptation period and the bed-rest
period of both studies. During studies A and B, the thickness of
the vastus lateralis muscle was measured while the subject was in
the supine position, by using ultrasound imaging on a portable
ultrasound device (MyLab25; ESAOTE, Genoa, Italy) fitted
with a 10–15-MHz linear probe (26). Sagittal ultrasound images
were obtained at 50% of muscle length measured along the mid-
sagittal axis, after identification of the proximal and medial bone
insertions of muscle. Muscle thickness was measured, and ex-
pressed in cm, as the vertical distance between muscle superficial
and deep aponeuroses at an equidistant point from the right and
left borders of the image. Only in study A, in addition to the
thickness of the vastus lateralis, the thicknesses of the gastroc-
nemius medialis, tibialis anterior, and biceps brachii muscles
were measured. Then, a mean value of the thickness of repre-
sentative postural and nonpostural muscles was calculated.
Markers of inflammatory response and erythrocyte glutathi-
one turnover rates were determined during the postabsorptive
state at the end of both the ambulatory adaptation and the bed-rest
periods in study A. After background blood sampling, a primed
continuous infusion of L-[3,3-2H2]cysteine (Cambridge Isotope
Laboratories, Andover, MA) (priming dose: 150 mol; contin-
uous infusion rate: 150 mol/h) was started at 0700 or 0800 and
continued for 5 h. A total of 10 mL arterialized venous blood was
obtained at times 3, 4, and 5 h to measure hematocrit and the
concentration and 2H2 enrichment of erythrocyte-free cysteine
and glutathione (24). Whole blood was immediately centrifuged,
and plasma and leukocytes were removed and replaced with an
equal volume of cold distilled water. Both plasma and erythro-
cyte solutions were frozen at 80 °C for later analysis. Plasma
and erythrocyte concentrations of glutathione and of glutathione
amino acid precursors were measured in the background sample.
At time 5 h, selected plasma hormone, mediator, and metabolite
concentrations were measured in plasma, and glutathione per-
oxidase activity and protein concentrations in the catalytic and
modulatory subunits of glutamate cysteine ligase were measured
in erythrocytes. At 1200 or 1300, isotope infusion was discon-
tinued.
All volunteers provided written informed consent. The exper-
imental protocols were approved by the Ethics Committee of the
University of Ljubljana (Ljubljana, Slovenia), and they con-
formed to the standards set by the Declaration of Helsinki (2002).
Analyses
The procedure for analysis of erythrocyte glutathione and cys-
teine isotopic enrichments was adapted from Lyons et al (24).
Erythrocyte suspension obtained from 400 L whole blood was
placed into already-chilled tubes containing 1 mL ice-cold di-
thiothreitol (20 mmol/L in 1 mol acetic acid/L). Proteins were
precipitated with 400L sulfosalicylic acid 30% and centrifuged
for 15 min at 10 000  g at 4 °C. The supernatant fluid was
transferred to a column containing 2 mL of a cation-exchange
resin (AG 50W-X8; Bio-Rad, Hercules, CA). After washing with
Milli-Q water [5 mL 2; Millipore, Bedford, MA), glutathione
was eluted from the column by using NH4OH (3 mol/L) and
collected into derivatization tubes (10 mL). Ammonia was elim-
inated under gentle nitrogen flow at room temperature. Samples
were frozen, lyophilized, and reacted with 500 L dithiothreitol
solution (20 mmol/L in 0.5 mol acetic acid/L) at 100 °C for 1 h
to reduce any dimerized glutathione and then dried again in
nitrogen flow. Each sample was reacted with 300L HCl/meth-
anol solution (250 L 36% HCl in 7.5 mL methanol), incubated
for 30 min at 80 °C, and dried in nitrogen flow at 65 °C before
being further reacted with 50 L N-methyl-N-tert-butyl-
dimethysilyl-trifluoroacetamide and 50 L acetonitrile for 40
min at 90 °C before injection into a gas chromatograph–mass
spectrometer [(GC-MS) HP 5890; Agilent Technologies, Santa
Clara, CA]. The GC-MS analyses of glutathione and cysteine
were carried out by using a fixed silica capillary column (HP-
5MS; Agilent Technologies: 25-mm internal diameter and
0.25-m film thickness). Column temperature was programmed
to rise by 10 °C/min from 160 to 300 °C (detector temperatures
were 260 °C) with the use of helium as the carrier gas. The
derivative was measured under electron-impact ionization by
selective ion monitoring at a nominal mass-to-charge ratio (m/z)
of 363/365 for glutathione enrichment and of 406/408 for cys-
teine enrichment.
Total glutathione concentrations in plasma and erythrocytes
obtained from background samples were measured by using
GC-MS and the internal standard technique. Briefly, known
amounts of [glycine-13C215N]glutathione (Cambridge Isotope
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Laboratories, Andover, MA) were added as internal standard to
erythrocyte suspension obtained from 400 L whole blood and
to 200 L plasma. Samples were processed as described above.
The derivative was measured under electron-impact ionization
by selective ion monitoring at a nominal m/z of 363/366. Plasma
and erythrocyte concentrations of glutathione precursor amino
acids (glycine, glutamine, glutamate, methionine, homocysteine,
and cysteine in plasma; glycine, glutamine, glutamate, methio-
nine, and cysteine in erythrocytes) were measured in background
samples by using GC-MS and the internal standard technique
according to Valerio et al (27). Briefly, known amounts of
L-[15N]glicine, L-[15N]glutamate, L-[15N]glutamine, DL-
[3,3,3,3,4,4,4,4-2H8]-homocysteine, L-[1-13C, methyl-2H3]
methionine, and L-[3,3-2H2]cysteine (Cambridge Isotope Labo-
ratories) were added as internal standards to an erythrocyte sus-
pension obtained from 400 L whole blood and to 200 L
plasma. Samples were processed as described (27). The deriva-
tive was measured under electron-impact ionization by selective
ion monitoring at a nominal m/z of 218/219 for glycine, 432/433
for glutamate, 431/432 for glutamine, 496/500 for homocysteine,
320/324 for methionine, and 406/408 for cysteine.
Plasma leptin concentrations were measured by using an
enzyme-linked immunosorbent assay (human Leptin Quantikine
kit, catalog #DLP00; R&D Systems, Minneapolis, MN). Plasma
C-reactive protein (CRP) concentrations were measured by us-
ing a high-sensitivity enzyme-linked immunosorbent assay kit
(Diagnostics Biochem, London, Canada). Plasma insulin con-
centrations were measured by using a radioimmunoassay (Adal-
tis insulin kit; Adaltis Inc, Montreal, Canada). Total plasma
ghrelin concentrations were measured by using a radioimmu-
noassay (Total Human Ghrelin, GHRT-89HK; Linco, St
Charles, MO). Plasma glucose, total cholesterol, HDL-
cholesterol, and triglyceride concentrations were measured by
using commercially available kits (Olympus System Reagents;
Olympus Diagnostica GmbH, Hamburg, Germany) by using an
autoanalyzer (Olympus AU400 System; Olympus, Tokyo, Ja-
pan). LDL cholesterol was calculated by using the Friedewald
equation: LDL cholesterol total cholesterol – HDL cholesterol
– (triglycerides 5) (28).
With antibodies obtained from rabbits and guinea pigs, neu-
trophil myeloperoxidase plasma concentrations were measured
with the use of an enzyme-linked immunosorbent assay (29).
Serum immunoglobulin G was isolated by affinity chromatog-
raphy after immunization with purified human neutrophil my-
eloperoxidase. A reference curve was performed with purified
human myeloperoxidase. Total –SH (thiol) functions (free –SH
or bound to proteins) were measured in plasma by using spec-
trophotometry (at 412 nm) after the reaction of –SH with 5,5
dithiobis-2-nitrobenzoic acid (30). A reference curve was per-
formed with reduced glutathione. Total –SH values were ex-
pressed as mol/g protein. Total proteins were measured by using
the Bio-Rad Protein Assay reagent and expressed in mg/mL.
Glutathione peroxidase activity was determined in erythrocytes
according to Paglia and Valentine (31) and expressed as mol
metabolized NADPH  min1  g protein1 in the presence of an
organic hydroperoxide (cumolhydroperoxide) and of reduced
glutathione as enzyme cofactor (31).
Catalytic and modulator subunit expression of glutamate-
cysteine ligase in erythrocytes was measured by Western blot
analysis (32). Briefly, proteins were extracted from red blood
cells by using a lysis buffer (45 mmol/L Tris-HCl, 0.2% N-
laurylsarcosine; Sigma-Aldrich, St Louis, MO) containing pro-
teinase and phosphatase inhibitors (0.2 mmol phenylmethane-
sulfonyl fluoride/L, 1 mmol dithiothreitol/L, 2g aprotinin/mL,
2g pepstatin/mL, 0.1 mmol NaF/mL, and 0.1 mmol Na3VO4/L;
all: Sigma-Aldrich). After centrifugation (10 min, RT, 16 00 g),
proteins were separated by sodium dodecyl sulfate–polacrylamide
gel electrophoresis and transferred to a nitrocellulose membrane
(Protran; Perkin Elmer, Boston, MA). Proteins were recognized
by using commercial antibodies raised against the catalytic
(GCLc: sc-22755) and modulator (GCLm: sc-22754) (both:
Santa Cruz Biotechnology Inc, Santa Cruz, CA) subunits of the
glutamate-cysteine ligase. Glyceraldehyde-3-phosphate dehy-
drogenase was recognized by commercial antibody (sc-25778;
Santa Cruz Biotechnology Inc). A goat anti-rabbit horseradish
peroxidase–conjugated immunoglobulin G (Sigma-Aldrich)
was used as secondary antibody. Protein complexes were de-
tected by enhanced chemiluminescence (Amersham Life Sci-
ences, Arlington Heights, IL) on photographic film (Kodak Bi-
omax Light Film; Sigma-Aldrich). Protein concentrations in the
catalytic and modulator subunits of glutamate-cysteine ligase
were measured by band densitometry as a ratio with
glyceraldehyde-3-phosphate dehydrogenase protein concentra-
tion (Model 45–700 Imaging Densitometer; Bio-Rad).
Calculations
Isotopic enrichments were expressed as tracer-to-tracee ra-
tio (TTR). Erythrocyte cysteine concentrations were mea-
sured in separate background samples by dividing internal
standard concentration by internal standard enrichment and
then normalizing by the erythrocyte volume obtained from
hematocrit. Erythrocyte glutathione concentrations were
measured in separate background samples by using a standard
calibration curve in which fixed amounts of internal standard
were added to variable known glutathione concentrations.
Values of glutathione concentrations were normalized by
erythrocyte volume (mol/L) obtained from hematocrit. Glu-
tathione fractional synthesis rate (FSR; in %/d) was calculated
as {[E(2H2glutathione)/t]/E(2H2cysteine)}  24  100,
where E(2H2glutathione)/t is the slope (TTR/h) of the regres-
sion line describing the rise in erythrocyte 2H2-glutathione en-
richment (TTR) as a function of time (hours) over the last 2 h of
isotope infusion, and E(2H2cysteine) is the mean steady-state
2H2-cysteine enrichment (TTR) in erythrocytes over the last 2 h
of isotope infusion. Glutathione absolute synthesis rate (mol 
L1  d1) was calculated by multiplying glutathione FSR by
erythrocyte glutathione concentration.
Statistical analysis
All data were presented as means  SEMs. Baseline data on
body weight, fat mass, fat-free mass, and vastus lateralis thick-
ness of subjects from study A (n 10) and study B (n 9) were
compared by unpaired t test. There were no significant differ-
ences in baseline data of subjects from study A and study B.
Results of subjects from studies A and B, evaluated in ambula-
tory and bed-rest conditions, were analyzed with a repeated-
measures analysis of variance (ANOVA), with activity (ambulatory
and bed rest) as within-subject factor and group (studies A and B) as
between-subject factor. There was no significant group (study A
or study B) bed rest interaction for investigated variables.
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To investigate the influence of energy balance on fat-free mass
and muscle atrophy progression during 35 d of bed rest, pooled
subjects from studies A and B (n 19) were divided in 2 groups
by using the median value of individual changes in fat mass as
threshold. The 10 subjects with fat mass gain greater than the
median value were assigned to a group defined as having a higher
energy balance (HEBAB; subscript letters indicate the study from
which subjects were taken, with “AB” indicating that subjects
were taken from both studies). Conversely, the 9 subjects with fat
mass changes lower than the median value were assigned to a
group defined as having a lower energy balance (LEBAB). There
were no significant differences (unpaired t test) in baseline data
(ie, body weight, fat mass, fat-free mass, and vastus lateralis
thickness) in subjects from the HEBAB and LEBAB groups. Re-
sults from the 2 groups, studied in ambulatory and bed-rest con-
ditions, were analyzed with a repeated-measures ANOVA, with
activity (ambulatory and bed rest) as within-subject factor and
group (higher and lower energy balance) as between-subject
factor. Post hoc analysis was performed, when appropriate (ie,
significant bed-rest effect and group bed rest interaction), by
t test with Bonferroni’s adjustment to assess the effects of bed rest
in either group.
To investigate the influence of energy balance on bed rest–
mediated changes in inflammatory markers and erythrocyte glu-
tathione turnover, subjects from study A (n 10) were divided
in 2 groups by using the median value of individual changes in fat
mass as threshold. Values of hormones, mediators, and sub-
strates concentrations were included in the analysis after log
transformation. Baseline data on subjects from higher (HEBA; n
 5) or lower (LEBA; n 5) energy-balance groups were com-
pared by using an unpaired t test. Results from the 2 groups,
studied in ambulatory and bed-rest conditions, were analyzed by
using a repeated-measures ANOVA, with activity (ambulatory
or bed rest) as within-subject factor and group (higher or lower
energy balance) as between-subject factor. Post hoc analysis was
performed, when appropriate (ie, significant bed-rest effect and
group bed rest interaction), by t test with Bonferroni’s adjust-
ment to assess the effects of bed rest in either group. All com-
parisons were considered significant at the conventional P 
0.05. The relations between variables were analyzed by bivariate
correlation using the Pearson’s coefficient. Statistical analysis
was conducted with SPSS statistical software (version 12; SPSS
Inc, Chicago, IL).
RESULTS
Body composition and muscle thickness (study A and
study B)
Baseline values of body weight, fat mass, fat-free mass, and
vastus lateralis thickness did not differ significantly (unpaired t
test) between subjects from study A and those from study B.
During 5 wk of bed rest, body weight decreased (P  0.001,
repeated-measures ANOVA) from 76.5 2.9 to 75.4 2.8 kg
in study A and from 76.3 3.7 to 73.9 3.5 kg in study B; fat
mass increased (P  0.02, repeated-measures ANOVA) from
10.2  1.6 to 11.9  1.6 kg in study A and from 13.6  2.1 to
14.4  2.3 in study B; fat-free mass decreased (P  0.001,
RM-ANOVA) from 66.3 2.1 to 63.4 1.9 kg in study A and
from 62.7  2.2 to 59.4  1.9 kg in study B; and thickness of
vastus lateralis decreased (P 0.02, RM-ANOVA) from 2.39
0.09 to 2.20 0.09 cm in study A and from 2.09 0.19 to 1.84
0.17 cm in study B. There were no significant group (study A or
study B)  bed rest interactions for body weight, fat mass, fat-
free mass, or vastus lateralis thickness. In subjects from study A,
the average thickness of the vastus lateralis, gastrocnemius me-
dialis, tibialis anterior, and biceps brachii decreased significantly
after bed rest (from 2.39 0.09 to 2.20 0.09 cm; P 0.001,
paired t test), and the decrease correlated directly with fat-free
mass both before (r 0.67, P 0.05; n 10) and at the end of
(r  0.63, P  0.05; n  10) the bed-rest period. Bed rest–
induced percentage changes in fat-free mass and average muscle
thickness were directly correlated (r 0.63, P 0.05; n 10).
To investigate the influence of energy balance on fat-free
mass and muscle atrophy progression during 35 d of bed rest,
pooled subjects from studies A and B were divided into 2
groups by using the median value of individual changes in fat
mass (ie, 1.4 kg) as threshold. The 10 subjects (7 from study
A and 3 from study B) with fat mass gain greater than the
median value were assigned to a group defined as higher
energy balance (HEBAB). Conversely, the 9 subjects (3 from
study A and 6 from study B) with fat mass changes lower than
the median value were assigned to a group defined as lower
energy balance (LEBAB) (Table 1). Baseline body weight, fat
mass, fat-free mass, and vastus lateralis thickness did not
differ significantly between the 2 groups (Table 1). There
TABLE 1
Effects of bed rest at different energy intakes on body weight, fat-free mass, and vastus lateralis thickness1
HEBAB (n 10)2 LEBAB (n 9) P3
Ambulatory Bed rest Ambulatory Bed rest Group effect Activity effect Interaction
Body weight (kg) 80.0 3.54 78.4 3.3 72.4 2.3 70.5 2.2 0.08 0.01 0.66
Fat-free mass (kg) 67.1 1.8 63.4 1.85 61.8 2.3 59.5 2.15 0.11 0.01 0.03
Vastus lateralis (cm) 2.43 0.13 2.10 0.135 2.04 0.15 1.95 0.15 0.19 0.001 0.01
1 HEBAB, higher energy balance; LEBAB, lower energy balance. Fat-free mass and vastus lateralis thickness were measured by using bioelectrical
impedance analysis and ultrasound imaging, respectively.
2 Subjects with HEBAB or LEBAB were identified according to the median value of inactivity-induced fat mass (bioimpedance) changes (increase of 1.4
kg) after bed-rest study A (10 subjects were allowed to spontaneously adapt to decreased energy requirement) was combined with bed-rest study B (9 subjects
were provided with an activity-adjusted diet). Baseline values of fat mass did not differ significantly between HEBAB (12.9 2.3 kg) and LEBAB (10.6 1.2
kg) groups. Changes in body fat in HEBAB and LEBAB groups averaged 2.1 0.4 and 0.4 0.3 kg, respectively.
3 Data were analyzed with the use of a 2-factor (group activity) ANOVA.
4 x  SEM (all such values).
5 Significantly different from the ambulatory adaptation condition, P 0.025 (Bonferroni’s post hoc analysis).
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were significant bed-rest effects and group  bed rest inter-
actions for fat-free mass and vastus lateralis thickness. Bed
rest–induced decreases in fat-free mass were greater in HEBAB
(3.8 0.4 kg) than in LEBAB (2.3 0.5 kg). Bed rest–induced
decreases in thickness of vastus lateralis were greater in HEBAB
(0.32 0.04 cm; ie, 14 2%) than in LEBAB (0.09 0.04 cm;
ie, 6 5%). There were significant bed-rest effects (P 0.001)
and group  bed rest interactions (P  0.01) for intracellular
water, as determined by multifrequency BIA. Intracellular water
decreased in HEBAB from 32.4  1.0 to 30.6  1.0 kg and in
LEBAB from 30.6  1.0 to 29.6  0.9 kg. Bed rest–induced
decreases in intracellular water were greater in HEBAB (1.90.2
kg) than in LEBAB (1.0 0.2 kg).
Inflammatory markers and erythrocyte glutathione
(study A)
To compare the influence of bed rest at different levels of
energy balance on inflammatory markers and antioxidant de-
fenses, subjects from study A were divided into 2 groups by using
the median value of individual changes in fat mass as threshold
(ie, 1.8 kg). The 5 subjects with fat mass gain greater than the
median value were assigned to a group defined as HEBA. Con-
versely, the 5 subjects with fat mass changes lower than the
median value were assigned to a group defined as LEBA.
Baseline values of fat mass were not significantly different in
the HEBA and LEBA groups. Before bed rest, absolute values
of fat mass directly correlated with plasma leptin concentra-
tions (r  0.72, P  0.05; n  10). There were significant
bed-rest effects and group  bed rest interactions for plasma
leptin concentration. Leptin significantly increased after bed
rest in the HEB group (105  19%) but did not change sig-
nificantly in the LEB group (Table 2). Bed rest significantly
increased plasma ghrelin and insulin concentrations, but there
were no group bed rest interactions for ghrelin and insulin.
Plasma glucose did not change significantly after bed rest in
either group. There were significant group  bed rest inter-
actions for plasma CRP and myeloperoxidase concentrations,
as markers of systemic inflammation. Bed rest–mediated
changes in CRP and myeloperoxidase concentrations in
pooled subjects were directly correlated (r 0.94, P 0.001,
n 10). Plasma total thiol group concentrations did not change
significantly after bed rest in either group. Finally, there was a
significant bed-rest effect in increasing triglyceride and LDL-
cholesterol concentrations.
Bed-rest effects at different EIs on plasma and erythrocyte
glutathione and glutathione precursor amino acid concentrations
are shown in Table 3. Plasma glutathione and glutathione pre-
cursor amino acid concentrations did not change significantly
after bed rest in the HEB or LEB group. We found a tendency
(P0.06) toward an effect of bed rest on glutathione and glycine
concentrations in erythrocytes, but no significant changes were
observed in the other amino acids. There was a significant (P
0.01) effect of bed rest in increasing hematocrit both in the HEB
(from 482% to 502%) and LEB (from 482% to 512%)
groups. However, there was no group bed rest interaction for
hematocrit. Precursor 2H2-cysteine enrichment was measured in
erythrocytes and reached steady state in all groups and conditions
by the end of the third hour of isotope infusion, whereas the 2H2
enrichment in erythrocyte glutathione increased linearly with
time (Figure 1 ).
The effects of bed rest at different EIs on the erythrocyte
glutathione system are shown in Table 4. Before bed rest, glu-
tathione absolute synthesis rates directly correlated with cysteine
concentrations in erythrocytes of pooled subjects (r 0.74, P
0.05; n  10). No significant correlations were found between
absolute gluthatione synthesis rates and glutamate (r0.13; n
 10) or glycine (r  0.50; n  10) concentrations. Bed rest
tended to increase glutathione fractional and absolute synthesis
rates in eythrocytes. There were significant group  bed rest
interactions for glutathione fractional and absolute synthesis
rates in eythrocytes. Bed rest–mediated changes in glutathione
fractional and absolute synthesis rates in eythrocytes were
greater in the HEBA group (94 18% and 215 42%, respec-
tively) than in the LEBA group (28  37% and 40  88%,
TABLE 2
Effects of bed rest at different energy intakes on plasma hormone, mediator, and substrate concentrations1
HEBA2 (n 5) LEBA2 (n 5) P3
Ambulatory Bed rest Ambulatory Bed rest Group effect Activity effect Interaction
Leptin (ng/mL) 3.4 1.24 6.9 2.65 2.1 0.6 3.2 1.2 0.51 0.01 0.04
Ghrelin (ng/mL) 986 79 766 39 1083 212 929 119 0.52 0.004 0.21
Insulin (U/mL) 8.1 1.2 12.0 1.7 8.1 0.8 11.2 2.3 0.77 0.05 0.65
Glucose (mg/dL) 88 1.2 89 2 92 3 87 3 0.59 0.41 0.32
CRP (g/mL) 0.4 0.2 0.8 0.5 1.5 0.6 0.7 0.2 0.32 0.35 0.02
Myeloperoxidase (ng/mL) 327 18 381 25 345 25 326 22 0.54 0.21 0.02
Total -SH (pmol/g protein) 3.7 1.0 3.2 0.5 4.1 0.7 4.3 0.8 0.41 0.79 0.60
Triglycerides (mg/dL) 71 10 100 37 98 18 158 30 0.15 0.01 0.27
HDL cholesterol (mg/dL) 43 2 40 2 45 3 40 2 0.78 0.09 0.58
LDL cholesterol (mg/dL) 94 6 120 7 104 7 126 8 0.27 0.007 0.61
1 HEBA, higher energy balance; LEBA, lower energy balance; CRP, C-reactive protein; -SH, thiol function.
2 Subjects with HEBA or LEBA were identified according to the median value of inactivity-induced fat mass (bioimpedance) changes (increase of 1.8 kg)
in bed-rest study A (10 subjects were allowed to spontaneously adapt to decreased energy requirement). Baseline values of fat mass did not differ significantly
between HEBA (11.6 2.6 kg) and LEBA (8.8 1.6 kg) groups. Changes in body fat in the HEBA and LEBA groups averaged 2.6 0.3 and 1.0 0.5 kg,
respectively.
3 Data were analyzed after log-transformation by using a 2-factor (group activity) ANOVA with interaction.
4 x  SEM (all such values).
5 Significantly different from the ambulatory adaptation condition, P 0.025 (Bonferroni’s post hoc analysis).
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respectively). There was a tendency toward a group  bed rest
interaction for the effects of bed rest at different EIs on the
catalytic subunit for glutamate cysteine ligase, the key enzyme
for glutathione synthesis; however, this trend was not statisti-
cally significant. Bed rest–mediated changes in the catalytic sub-
unit for glutamate cysteine ligase tended to be greater in the
HEBA group (96 65%) than in the LEBA group (10 35%).
Bed rest at different EIs did not significantly affect glutathione
peroxidase activity.
DISCUSSION
In healthy humans, physical inactivity is frequently associated
with overfeeding and with increased fat mass. We monitored
body composition and thickness of the vastus lateralis muscle in
healthy volunteers during 35 d of bed rest at different EIs. Most
of the subjects accumulated body fat to various degrees. Those
who gained more fat suffered the greatest loss of skeletal muscle
and fat-free mass. Positive energy balance and muscle atrophy
were associated with activation of the systemic inflammatory
response and antioxidant defenses.
We used 2 independent methods to assess the effects of bed
rest at various levels of energy balance on skeletal muscle and
fat-free mass. BIA is a validated method for assessing fat mass
and fat-free mass in healthy persons; the latter measure is a close
marker of whole-body muscle mass (22). Muscle atrophy assess-
ment was directly performed by ultrasonography measurement
of muscle thickness. This is a validated technique for assessing
muscle size (26, 33). Thickness of the vastus lateralis, a key
postural and locomotor muscle, and total-body fat-free mass
decreased after bed rest in subjects with greater increases in body
fat more than it decreased in those with smaller changes in body
fat. The average thickness of representative postural (vastus late-
ralis, gastrocnemius medialis, and tibialis anterior) and nonpos-
tural (biceps brachii) muscles correlated directly with whole-
body fat-free mass, as determined by BIA, both before and at the
end of the bed-rest period.
Glutathione plays a major role in cellular defenses against
oxidative stress (20). Higher concentrations are present in eryth-
rocytes, providing both local and systemic antioxidant protection
(21). Different components of glutathione system in erythrocytes
were considered. Glutathione synthetic capacity was assessed by
TABLE 3
Effects of bed rest at different energy intakes on plasma and erythrocyte glutathione and glutathione precursor amino acid concentrations1
HEBA2 (n 5) LEBA2 (n 5) P3
Ambulatory Bed rest Ambulatory Bed rest Group effect Activity effect Interaction
Plasma (mol/L)
Glutathione 24 34 23 4 29 2 27 1 0.16 0.61 0.76
Glycine 240 23 240 18 242 16 217 12 0.63 0.40 0.42
Glutamine 501 33 562 17 514 35 487 31 0.25 0.64 0.24
Glutamate 88 6 86 9 82 4 85 15 0.75 0.99 0.80
Methionine 25 2 27 2 27 2 25 2 0.93 0.90 0.15
Homocysteine 18 2 18 1 13 2 12 2 0.06 0.17 0.69
Cysteine 27 1 26 1 27 2 25 2 0.96 0.22 0.47
Erythrocyte (mol/L)
Glutathione 2152 209 2254 115 2160 85 2394 131 0.70 0.06 0.42
Glycine 404 22 396 16 451 29 363 23 0.78 0.06 0.11
Glutamine 475 33 483 10 496 22 451 32 0.88 0.23 0.09
Glutamate 458 74 443 75 420 17 462 57 0.90 0.67 0.37
Methionine 25 3 29 3 28 2 29 2 0.62 0.24 0.52
Cysteine 67 13 75 13 69 16 66 11 0.82 0.80 0.64
1 HEBA, higher energy balance; LEBA, lower energy balance.
2 Subjects with HEBA or LEBA were identified according to the median value of inactivity-induced fat mass (bioimpedance) changes (increase in 1.8 kg)
in bed-rest study A (10 subjects were allowed to spontaneously adapt to decreased energy requirement). Baseline values of fat mass did not differ significantly
between HEBA (11.6  2.6 kg) and LEBA (8.8  1.6 kg) groups. Changes in body fat in HEBA and LEBA groups averaged 2.6  0.3 and 1.0  0.5 kg,
respectively.
3 Data were analyzed by using a 2-factor (group diet) ANOVA with interaction.
4 x  SEM (all such values).
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FIGURE 1. Mean  SEM precursor 2H2-cysteine and product 2H2-
glutathione tracer-to-tracee ratios (TTRs) in erythrocytes during primed con-
tinuous infusion of 2H2-cysteine, before (F) and at the end of (E) 35-d bed
rest, in the higher-energy-balance (HEBA, n 5) and lower-energy-balance
(LEBA, n 5) groups.
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Western blot determination of expression levels of catalytic and
modulatory subunits of the glutamate-cysteine ligase enzyme,
which catalyzes the rate-limiting step in glutathione biosynthesis
(32). The actual rate of glutathione turnover was determined by
using a primed continuous infusion of deuterated cysteine and by
monitoring incorporation of the labeled precursor into glutathi-
one by MS analysis (24), whereas glutathione function was eval-
uated through measurement of glutathione peroxidase activity
(31). We found group  bed rest interactions for the catalytic
subunit of the glutamate-cysteine ligase enzyme and the rate of
glutathione turnover leading to greater bed rest–mediated in-
creases in glutathione synthesis in the HEB than in the LEB
group. Glutathione peroxidase activity did not change in the 2
groups. Our results indicate that the erythrocyte glutathione sys-
tem is greatly activated during bed rest at positive energy bal-
ance, whereas bed rest at near-neutral balance is not associated
with significant changes in glutathione synthesis.
Evidence indicates that glutathione synthesis is up-regulated
by proinflammatory mediators and oxidative stress (20). We
found significant group bed rest interactions for plasma CRP
and myeloperoxidase concentrations, which led to greater bed
rest–mediated increases of these mediators in the HEB group
than in the LEB group. Plasma CRP and myeloperoxidase are
suitable markers of activation of systemic inflammation (34).
These results strongly suggest that an activation of the erythro-
cyte glutathione system is part of the systemic inflammatory and
stress reaction to bed rest at positive energy balance. Inflamma-
tory response and redox unbalance could mediate lean body mass
catabolism during bed rest at positive energy balance (17–19). In
addition, an increased ghrelin response after a period of over-
feeding (35) could contribute to an enhancement of muscle ca-
tabolism (36).
One limitation of the present study is that, typically, only a
small number of persons can be enrolled in bed-rest studies. The
effect of positive energy balance on inactivity-induced muscle
atrophy was assessed by combining the results of 2 bed-rest
studies, conducted under the same experimental conditions, to
achieve a sample size of 19 subjects. In contrast, energy level
bed rest interactions for inflammatory markers and glutathione
kinetics were assessed in 2 groups of only 5 subjects. Although
extending these observations in a larger population would rein-
force the present findings, but we were able to detect significant
differences in key markers of inflammatory response and gluta-
thione kinetics.
Positive energy balance (ie, EI in excess of requirements)
leads to fat deposition, and changes in body fat mass closely
reflect energy balance over the long term, even in the presence of
atrophying muscles. In fact, energy density of fat tissue is 9 times
that of muscle and fat-free mass (37). Our study A subjects were
allowed to spontaneously adapt to decreased energy requirement
during bed rest, whereas study B subjects were provided an
activity-adjusted diet (1.2 times their calculated resting energy
expenditure). At the end of the bed-rest periods, 9 of 10 study A
subjects and 5 of 9 study B participants had gained 0.5 kg fat
mass. Thus, study A subjects failed to spontaneously adapt to a
lower energy requirement, whereas, in study B, an activity-
adjusted diet based on traditional predictive equations (22, 38)
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FIGURE 2. Relation between average values of absolute changes in fat
mass and lean mass (by dual-energy X-ray absorptiometry) or fat-free mass
(by bioelectrical impedance analysis) in previous studies and in the present
study. Letters inside (or just outside of) circles represent values from these
studies: a, Barbe et al (10); b, Scheld et al (13); c, Stein et al (12); d, present
study, lower-energy-balance group; e, Blanc et al (6); f, Krebs et al (7); g,
Lovejoy et al (11); h, Gretebeck et al (8); i, present study, higher-energy-
balance group; j, Ferrando et al (9); and k, Olsen et al (5). r  0.85, P 
0.001; n 11.
TABLE 4
Effects of bed rest at different energy intakes on glutathione status in erythrocytes1
HEBA2 (n 5) LEBA2 (n 5) P3
Ambulatory Bed rest Ambulatory Bed rest Group effect Activity effect Interaction
Glutathione FSR (%/d) 70 194 164 295 103 23 84 27 0.43 0.13 0.03
Glutathione ASR (mmol  L1d1) 160 58 376 755 217 43 197 62 0.40 0.09 0.05
GCL-C (fraction of GAPDH) 0.95 0.23 1.36 0.15 1.73 0.57 1.01 0.28 0.58 0.63 0.10
GCL-M (fraction of GAPDH) 0.42 0.11 0.48 0.13 0.57 0.10 0.63 0.21 0.36 0.68 0.99
GPX activity (mol  min1  g protein1) 1.04 0.13 1.01 0.31 1.18 0.54 1.46 0.32 0.48 0.71 0.65
1 HEBA, higher energy balance; LEBA, lower energy balance; FSR, fractional synthesis rate; ASR, absolute synthesis rate; GCL-C, glutamate cysteine
ligase–catalytic subunit; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GCL-M, glutamate cysteine ligase–modulator subunit; GPX, glutathione
peroxidase.
2 Subjects with HEBA or LEBA were identified according to median value of inactivity-induced fat mass (bioimpedance) changes (increase of 1.8 kg) in
bed-rest study A (10 subjects were allowed to spontaneously adapt to decreased energy requirement). Baseline values of fat mass did not differ significantly
between HEBA (11.6  2.6 kg) and LEBA (8.8  1.6 kg) groups. Changes in body fat in HEBA and LEBA groups averaged 2.6  0.3 and 1.0  0.5 kg,
respectively.
3 Data were analyzed by using a 2-factor (group activity) ANOVA with interaction.
4 x  SEM (all such values).
5 Significantly different from the ambulatory condition, P 0.025 (Bonferroni’s post hoc analysis).
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overestimated the true requirement for most subjects. Achieve-
ment of energy balance during experimental bed rest is a difficult
task that involves constant monitoring of individual energy re-
quirements and intakes, and that goal has rarely been attained in
previous investigations. Results obtained in the present study and
in 9 previously reported bed-rest studies that found positive mean
changes in fat mass (6–14) are shown in Figure 2. Changes in fat
mass are related to changes in lean body mass (by dual-energy
X-ray absorptiometry) or fat-free mass (by BIA). A gain of body
fat and a loss of lean (fat-free) mass are expressed as weekly
percentage changes from baseline. Linear regression analysis
indicates an indirect relation between fat gain and lean (fat-free)
mass loss, regardless of the duration of inactivity (Figure 2).
Similar results are obtained by excluding the present study from
the analysis (r  0.97). Thus, there is excellent agreement
between the retrospective analysis (6–14; Figure 2) and the re-
sults from the present study, which suggest that, when EI is not
strictly controlled during bed rest, fat mass tends to increase in
parallel with lean body mass catabolism.
The present study shows that excess fat deposition during
physical inactivity is associated with greater muscle loss and
greater activation of systemic inflammation and antioxidant de-
fenses. These mechanisms potentially contribute to long-term
changes in body composition and to the cardiometabolic risk
observed in sedentary persons (39, 40).
We thank the volunteers, who gave their time and effort to ensure the
success of this project. We acknowledge the excellent assistance of the entire
staff of the Valdoltra Orthopaedic Hospital of Ankaran (Koper, Slovenia).
We acknowledge the valuable dietetic assistance of Lilijana Vouk-Grbac and
the excellent nursing assistance of Oiviera Bosnjak. We thank Bruno Biasioli
and Gianfranco Cortelli (Dipartimento di Medicina di Laboratorio, Ospedale
Maggiore, Trieste, Italy) for valuable methodologic advice and help with
analyses. The present work was supported by grants from the Italian Space
Agency (OSMA project), the Slovenian Minister of Defense and the Regione
Friuli Venezia Giulia (LR11).
The authors’ responsibilities were as follows—GB: design of the exper-
iment, collection and analysis of data, and writing of the manuscript; FA:
design of the experiment, collection and analysis of data, and writing of the
manuscript; BS: design of the experiment and collection of data; MS: col-
lection and analysis of data; LT: design of the experiment and statistical
analysis of data; JCP: collection and analysis of data; GD-D: collection and
analysis of data; PM, analysis of data; FS: collection and analysis of data;
PdP: design of the experiment; GG: design of the experiment; IBM: design
of the experiment and collection and analysis of data; MVN: design of the
experiment and collection and analysis of data; and RP: design of the exper-
iment, collection and analysis of data, and writing of the manuscript. None of
the authors had a personal or financial conflict of interest.
REFERENCES
1. Zhong H, Roy RR, Siengthai B, Edgerton VR. Effects of inactivity on
fiber size and myonuclear number in rat soleus muscle. J Appl Physiol
2005;99:1494–9.
2. di Prampero PE, Narici MV. Muscles in microgravity: from fibres to
human motion. J Biomech 2003;36:403–12.
3. Stuart CA, Shangraw RE, Prince MJ, Peters EJ, Wolfe RR. Bed-rest-
induced insulin resistance occurs primarily in muscle. Metabolism 1988;
37:802–6.
4. Blanc S, Normand S, Ritz P, et al. Energy and water metabolism, body
composition, and hormonal changes induced by 42 days of enforced
inactivity and simulated weightlessness. J Clin Endocrinol Metab 1998;
83:4289–97.
5. Olsen RH, Krogh-Madsen R, Thomsen C, Booth FW, Pedersen BK.
Metabolic responses to reduced daily steps in healthy nonexercising
men. JAMA 2008;299:1261–3.
6. Blanc S, Normand S, Pachiaudi C, Duvareille M, Gharib C. Leptin
responses to physical inactivity induced by simulated weightlessness.
Am J Physiol Regul Integr Comp Physiol 2000;279:R891–8.
7. Krebs JM, Schneider VS, Evans H, Kuo MC, LeBlanc AD. Energy
absorption, lean body mass, and total body fat changes during 5 weeks of
continuous bed rest. Aviat Space Environ Med 1990;61:314–8.
8. Gretebeck RJ, Schoeller DA, Gibson EK, Lane HW. Energy expenditure
during antiorthostatic bed rest (simulated microgravity). J Appl Physiol
1995;78:2207–11.
9. Ferrando AA, Lane HW, Stuart CA, Davis-Street J, Wolfe RR. Pro-
longed bed rest decreases skeletal muscle and whole body protein syn-
thesis. Am J Physiol 1996;270:E627–33.
10. Barbe P, Galitzky J, Thalamas C, et al. Increase in epinephrine-induced
responsiveness during microgravity simulated by head-down bed rest in
humans. J Appl Physiol 1999;87:1614–20.
11. Lovejoy JC, Smith SR, Zachwieja JJ, et al. Low-dose T(3) improves the
bed rest model of simulated weightlessness in men and women. Am J
Physiol 1999;277:E370–9.
12. Stein TP, Leskiw MJ, Schluter MD, et al. Energy expenditure and bal-
ance during spaceflight on the space shuttle. Am J Physiol 1999;276:
R1739-48.
13. Scheld K, Zittermann A, Heer M, et al. Nitrogen metabolism and bone
metabolism markers in healthy adults during 16 weeks of bed rest. Clin
Chem 2001;47:1688–95.
14. Shackelford LC, LeBlanc AD, Driscoll TB, et al. Resistance exercise as
a countermeasure to disuse-induced bone loss. J Appl Physiol 2004;97:
119–29.
15. Schaffler A, Muller-Ladner U, Scholmerich J, Buchler C. Role of adi-
pose tissue as an inflammatory organ in human diseases. Endocr Rev
2006;27:449–67.
16. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA.
Influence of metabolic syndrome on biomarkers of oxidative stress and
inflammation in obese adults. Obesity 2006;14:2127–31.
17. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and
loss of muscle mass (sarcopenia) and strength. Am J Med 2006;119:
526–17.
18. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse
muscle atrophy. J Appl Physiol 2007;102:2389–97.
19. Glick Z, McNurlan MA, Garlick PJ. Protein synthesis rate in liver and
muscle of rats following four days of overfeeding. J Nutr 1982;112:
391–7.
20. Lu SC. Regulation of hepatic glutathione synthesis: current concepts and
controversies. FASEB J 1999;13:1169–83.
21. Richards RS, Roberts TK, Dunstan RH, McGregor NR, Butt HL. Eryth-
rocyte antioxidant systems protect cultured endothelial cells against
oxidant damage. Biochem Mol Biol Int 1998;46:857–65.
22. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance
analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430–
53.
23. Badman MK, Flier JS. The adipocyte as an active participant in energy
balance and metabolism. Gastroenterology 2007;132:2103–15.
24. Lyons J, Rauh-Pfeiffer A, Yu YM, et al. Blood glutathione synthesis
rates in healthy adults receiving a sulfur amino acid-free diet. Proc Natl
Acad Sci U S A 2000;97:5071–6.
25. Mu¨ller MJ, Bosy-Westphal A, Klaus S, et al. World Health Organization
equations have shortcomings for predicting resting energy expenditure
in persons from a modern, affluent population: generation of a new
reference standard from a retrospective analysis of a German database of
resting energy expenditure. Am J Clin Nutr 2004;80:1379–90.
26. Reeves ND, Maganaris CN, Narici MV. Ultrasonographic assessment of
human skeletal muscle size. Eur J Appl Physiol 2004;91:116–8.
27. Valerio A, Baldo G, Tessari P. A rapid method to determine plasma
homocysteine concentration and enrichment by gas chromatography/
mass spectrometry. Rapid Commun Mass Spectrom 2005;19:561–7.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concen-
tration of low-density lipoprotein cholesterol in plasma, without use of
the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
29. Franck T, Grulke S, Deby-Dupont G, et al. Development of an enzyme-
linked immunosorbent assay for specific equine neutrophil myeloper-
oxidase measurement in blood. J Vet Diagn Invest 2005;17:412–9.
30. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonpro-
tein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem
1968;25:192–205.
31. Paglia DE, Valentine WN. Studies on the quantitative and qualitative
ENERGY INTAKE AND MUSCLE CATABOLISM 957
D
ow
nloaded from
 https://academ
ic.oup.com
/ajcn/article/88/4/950/4650237 by guest on 29 August 2020
characterization of erythrocyte glutathione peroxidase. J Lab Clin Med
1967;70:158–69.
32. Thompson SA, White CC, Krejsa CM, Eaton DL, Kavanagh TJ. Mod-
ulation of glutathione and glutamate-L-cysteine ligase by methylmer-
cury during mouse development. Toxicol Sci 2000;57:141–6.
33. Miyatani M, Kanehisa H, Kuno S, Nishijima T, Fukunaga T. Validity
of ultrasonograph muscle thickness measurements for estimating
muscle volume of knee extensors in humans. Eur J Appl Physiol
2002;86:203– 8.
34. Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated ox-
idants and atherosclerosis. Free Radic Biol Med 2000;28:1717–25.
35. Robertson MD, Henderson RA, Vist GE, Rumsey RD. Plasma ghrelin
response following a period of acute overfeeding in normal weight men.
Int J Obes Relat Metab Disord 2004;28(6):727–33.
36. Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin
in patients with COPD. Chest 2005;128(3):1187–93.
37. FAO/WHO/UNU. Estimates of energy and protein requirements of
adults and children. In: Energy and protein requirements. Report of a
joint FAO/WHO/UNU Expert Consultation. World Health Org Tech
Rep Ser 1985:724:71–112.
38. Biolo G, Ciocchi B, Stulle M, et al. Calorie restriction accelerates the
catabolism of lean body mass during 2 wk of bed rest. Am J Clin Nutr
2007;86:366–72.
39. Blankenberg S, Rupprecht HJ, Bickel C, et al. Glutathione peroxidase 1
activity and cardiovascular events in patients with coronary artery dis-
ease. N Engl J Med 2003;349:1605–13.
40. Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and
cardiometabolic risk: a consensus statement from Shaping America’s
Health: Association for Weight Management and Obesity Prevention;
NAASO, The Obesity Society; the American Society for Nutrition; and
the American Diabetes Association. Am J Clin Nutr 2007;85:1197–202.
958 BIOLO ET AL
D
ow
nloaded from
 https://academ
ic.oup.com
/ajcn/article/88/4/950/4650237 by guest on 29 August 2020
